Luis Ruiz-Brieva

Lleida, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.

Journal: Journal of medical economics

Published: June 24, 2026

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 20, 2026

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 08, 2025

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management.

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management.

Journal: Therapeutic advances in neurological disorders

Published: April 12, 2024

Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.

Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.

Journal: Scientific reports

Published: March 09, 2023

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.

Journal: Neurologia

Published: March 09, 2023

Preventive treatment can reverse cognitive impairment in chronic migraine.

Preventive treatment can reverse cognitive impairment in chronic migraine.

Journal: The journal of headache and pain

Published: July 05, 2022

The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2.

The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 11, 2022

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 01, 2021

Gadolinium-enhanced brain lesions in multiple sclerosis relapse.

Gadolinium-enhanced brain lesions in multiple sclerosis relapse.

Journal: Neurologia

Published: August 10, 2021

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026